Your selection
Research / 06.02.2026
Professorship awarded to Mina Gouti
Mina Gouti has been awarded a professorship at Charité – Universitätsmedizin Berlin. The appointment will strengthen her pioneering organoid research at the Max Delbrück Center and deepen collaboration with clinicians to advance personalized medicine.
Dr. Mina Gouti, Group Leader of the Stem Cell Modeling of Development and Disease lab at the Max Delbrück Center, has been appointed W3 Professor of Complex Organoid Models for Personalized Medicine in the Medical Faculty, Charité – Universitätsmedizin Berlin. The permanent position recognizes her achievements in developing advanced organoid systems to understand how specific types of spinal cord neurons and skeletal muscle cells grow in space and time during development.
“This professorship will enable my team to fully leverage Berlin’s exceptional biomedical ecosystem and to work closely with clinicians at Charité to create complex organoids for personalized medicine,” Gouti says. This close interaction is essential for translating patient-derived organoid models into clinically relevant insights.”
The Gouti lab has developed three-dimensional neuromuscular organoids from human pluripotent stem cells that replicate key features of spinal cord neurons and skeletal muscle – providing powerful platforms for studying neuromuscular diseases such as spinal muscular atrophy and amyotrophic lateral sclerosis, and for drug screening. Such organoids can also be grown from cells derived from individual patients to model their specific disease.
The position reflects a shared vision between the Max Delbrück Center and Charité to accelerate translational research through fostering closer collaboration between clinicians researchers. “We now have the long-term perspective required to develop complex, functional organoids as predictive platforms for personalized medicine and early disease interception,” says Gouti. “We hope our research will lead to better health outcomes not only for people with neuromuscular diseases, but also those at high risk of developing them.”
Text: Gunjan Sinha
Further information
Overview News
News Buch Berlin
ERC Advanced Grants awarded to two Berlin researchers
Uwe Ohler and Gaetano Gargiulo have been awarded prestigious ERC Advanced Grants. With funding of €2.5 million each, they will spend the next five years investigating how protein synthesis is regulate...
more ...Eckert & Ziegler and DC Pharma Open Commercial Medical Isotope Production Site in Jintan
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today officially opened the new medical isotope production site of its joint venture Qi Kang Medical Technology (Changzhou) Co., Ltd. (QKM) in the Jinta...
more ...Berlin honors outstanding deep-tech companies—including MyoPax
This year, for the first time, a Deep Tech Award was presented in the Bio & Health Tech category. The winner is MyoPax, a spin-off of the Max Delbrück Center and Charité.
more ...Events Buch Berlin
27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)
Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...
more ...22.09.2026, 09:00
GMP Biotech Summer School
Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.
more ...09.11.2026, 09:00
Fachkraft für Molekularbiologie
Elftägiges Intensivseminar der Berlin BioScience Academy. Es rmittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschu...
more ...